Rajwade Birendra K, Patel Ravi V, Jain Yugal D, Bhoge Rajendra P, Sharma Pradeep P
General Surgery, Jehangir Hospital, Pune, IND.
Cureus. 2022 Sep 19;14(9):e29341. doi: 10.7759/cureus.29341. eCollection 2022 Sep.
Background Ventralex® ST (Bard Davol Inc, Warwick, RI) patch is a composite self-expanding and non-absorbable mesh used to reinforce ventral hernia repair. This study was conducted to assess the efficacy, post-operative clinical outcomes, the duration of operation, and complications deciding the post-operative duration/need of hospitalization in patients of small ventral hernia after their open surgical repair using Ventralex ST hernia patch. Materials and methods We included 36 patients diagnosed with a small (<2 cm defect size) ventral hernia who underwent open mesh repair following strict surgical methodology using Ventralex® ST hernia patch between September 2018 and April 2020. It was a prospective observational study. Clinically relevant characteristics, along with operative and post-operative data collected through direct interview, clinical examination, and a pretested proforma, were analyzed prospectively. Results Thirty-four patients (94.5%) were observed to have an operative time of fewer than 60 minutes, with an average duration of 30-40 minutes. Thirty-one patients (86%) were discharged within 48 hours of surgery, out of which 17 patients (47.2%) were discharged within 24 hours of surgery and 14 patients (38.8%) within 48 hours. Only five patients (13.88%) had a prolonged hospital stay for more than 48 hours due to post-operative complications. Three patients (8.33%) acquired post-surgical wound infection, whereas two (5.55%) developed seroma. Nevertheless, just one patient (2.7%) reportedly developed both infection and seroma after surgery. No cases of mesh infection or recurrences were noted. Conclusion This study demonstrates that open repair of small (<2 cm defect size) ventral hernia using the Ventralex® ST hernia patch can be an extremely safe and effective method. Furthermore, it has excellent clinical outcomes when meticulously used with an easily reproducible surgical technique, which requires less intra-operative time, has minimal post-operative complications and negligible recurrence rate, along with reduced post-op hospital stay (86% of patients being discharged within 48 hours).
Ventralex® ST（巴德达沃尔公司，罗德岛州沃里克）补片是一种用于加强腹疝修补的复合自膨胀且不可吸收的补片。本研究旨在评估使用Ventralex ST疝补片对小型腹疝患者进行开放手术修补后的疗效、术后临床结局、手术时长以及决定术后住院时长/需求的并发症情况。
我们纳入了36例被诊断为小型（缺损尺寸<2 cm）腹疝的患者，这些患者于2018年9月至2020年4月期间，按照严格的手术方法使用Ventralex® ST疝补片接受了开放补片修补术。这是一项前瞻性观察研究。通过直接访谈、临床检查以及预先测试的表格收集的临床相关特征以及手术和术后数据进行了前瞻性分析。
观察到34例患者（94.5%）手术时间少于60分钟，平均时长为30 - 40分钟。31例患者（86%）在术后48小时内出院，其中17例患者（47.2%）在术后24小时内出院，14例患者（38.8%）在48小时内出院。仅5例患者（13.88%）因术后并发症住院时间延长超过48小时。3例患者（8.33%）发生了手术切口感染，而2例（5.55%）出现了血清肿。不过，据报道仅有1例患者（2.7%）术后同时发生了感染和血清肿。未发现补片感染或复发病例。
本研究表明，使用Ventralex® ST疝补片对小型（缺损尺寸<2 cm）腹疝进行开放修补可能是一种极其安全有效的方法。此外，当与易于重复的手术技术精心配合使用时，它具有出色的临床结局，所需手术时间较少，术后并发症极少，复发率可忽略不计，同时术后住院时间缩短（86%的患者在48小时内出院）。
